Sponsors once again want the rest of the US Food and Drug Administration to embrace an idea pioneered by the oncology review divisions, this time to improve the formal meeting process.
Formal meetings often are used by sponsors and the FDA to discuss complicated scientific questions or resolve problems that have...






